GOODWILL(SH:688246) Zhong Guo Jing Ji Wang·2025-04-30 06:55Financial Performance - In 2024, the company reported a revenue of 591.94 million yuan, a decrease of 14.85% compared to 2023 [1][2] - The net profit attributable to shareholders was -256.12 million yuan, down from a profit of 32.28 million yuan in the previous year [1][2] - The net profit attributable to shareholders after deducting non-recurring gains and losses was -261.38 million yuan, compared to 25.45 million yuan in 2023, marking a decline of 1,126.89% [1][2] - The net cash flow from operating activities was -67.63 million yuan [1][2] Q1 2025 Performance - For the first quarter of 2025, the company achieved a revenue of 101 million yuan, a year-on-year decline of 17.43% [1][2] - The net profit attributable to shareholders for Q1 2025 was -17.43 million yuan, compared to -11.85 million yuan in the same period last year [1][2] - The net profit after deducting non-recurring gains and losses was -17.96 million yuan, down from -13.03 million yuan in Q1 2024 [1][2] - The net cash flow from operating activities for Q1 2025 was -94.06 million yuan [1][2] Company Background - The company was listed on the Shanghai Stock Exchange's Sci-Tech Innovation Board on December 14, 2021, with an initial offering price of 39.50 yuan per share [4] - The total funds raised from the initial public offering amounted to 1.362 billion yuan, with a net amount of 1.24 billion yuan after deducting issuance costs [4] - The company planned to use the raised funds for various projects, including the development of specialized electronic medical records and upgrading data centers [4]